BLGTY Stock UPDATES Bio-Light Israeli (BLGTY) 3.9000 09/23/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Light Israeli (BLGTY) 3.9000 $BLGTY

Merriman Capital Announces Sponsorship of BioLight Life Sciences Investments Ltd. on OTCQX
Thomson Reuters ONE - 40 mins ago
SAN FRANCISCO - September 23, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will serve as the Principal American Liaison (PAL) for BioLight Life Sciences Investments Ltd. (OTCQX: BLGTY) ("BioLight" as it continues trading on OTCQX(R).

BioLight Announces First IOPtiMate(TM) System Sale in Hong Kong
PR Newswire - Wed Sep 10, 7:49AM CDT
BioLight Life Sciences Investments Ltd. (TASE: BOLT, OTCQX:BLGTY), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate(TM) system in Hong Kong.

BioLight Announces Issuance of U.S. Patent for the Long-Term Controlled-Release Drug-Delivery Insert Platform
PR Newswire - Wed Jul 02, 8:23AM CDT
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT) (OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the U.S. Patent and Trademark Office has issued patent number 8,765,166 covering the device that is inserted into the eye to treat an ocular condition that contains an active agent of a free acid salt form of a prostaglandin with a low elution rate profile that is contained in the long-term controlled-release insert platform. The patent will be in effect at least until May 2031. This patent covers the technology used in Eye-D®, the company's controlled-release latanoprost insert currently in a Phase 1/2a clinical study in the U.S. for the treatment of glaucoma.

BioLight Reports Successful Interim Results from Bladder Cancer Clinical Study
PR Newswire - Tue Jul 01, 4:23PM CDT
BioLight Life Sciences Investments Ltd. (OTC: BLGTY)(TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, achieved successful interim results in a blinded bladder cancer clinical trial with its CellDetect® technology. As a result, Micromedic will continue the trial with the goal of developing a kit for monitoring the recurrence of bladder cancer. This study is being conducted at seven medical centers and is expected to be completed in the fourth quarter of 2014.

First Patient Enrolled in FDA Phase 1/2a Clinical Trial With BioLight's Controlled-Release Latanoprost Insert for the Treatment of Glaucoma
PR Newswire - Mon Jun 30, 8:00AM CDT
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT)(OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D®, the company's controlled-release latanoprost insert for the treatment of glaucoma.

BioLight Raises NIS 19 Million, Announces China Regulatory Approval for IOPtiMate(TM) for Glaucoma Surgery
PR Newswire - Thu Mar 06, 11:07AM CST
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT; OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the successful completion of an equity financing that raised gross proceeds of approximately NIS 19 million (USD 5.5 million).




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 79

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 16

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 607

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 400

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 193

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 96

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

NYSPCC's Gala Honoring Child Welfare Advocates Shines Bright

Updated Category News Views 69

Celebrating a Night of Change for Children The New York Society for the Prevention of Cruelty to Children (NYSPCC), acclaimed for its significant role in child protection, celebrated a remarkable annual Fall Gala. This grand event, held recently at the iconic Rainbow Room, was an opportunity to honor remarkable individuals who have made substantial contributions to child...

Continue Reading
Rosen Law Firm Calls for FTAI Aviation Ltd. Investor Support

Updated Category News Views 174

Rosen Law Firm Calls for FTAI Aviation Ltd. Investor Support Rosen Law Firm, a prominent global lawyer advocacy firm, has made headlines by urging shareholders of FTAI Aviation Ltd. (NASDAQ: FTAI) to consider their rights after significant losses. The firm has learned about a class action lawsuit on behalf of all buyers of FTAI's common stock from the time frame that...

Continue Reading
Ally Financial Streamlines Operations Amid Economic Shifts

Updated Category News Views 126

Ally Financial Adjusts Strategy in Response to Market Changes Ally Financial (NYSE: ALLY) is making significant adjustments to its business model as it plans to exit the mortgage origination space and reduce its workforce. This decision has been influenced by the escalating credit challenges and the impact of rising interest rates affecting consumers. Workforce Reductions...

Continue Reading
Empowering Young Voices: NFL and Clubs Unite for Change

Updated Category News Views 206

Empowering Young Voices: NFL and Clubs Unite for Change For the first time in its history, the NFL has partnered with the Boys & Girls Clubs of America to send three remarkable young advocates to Super Bowl LIX. This historic collaboration represents not only a celebration of football but also a commitment to empowering youth to be catalysts for change in their...

Continue Reading
Understanding Price-to-Earnings Ratio for Annaly Capital

Updated Category News Views 132

Understanding Price-to-Earnings Ratio Currently, Annaly Capital Management Inc. (NYSE: NLY) trades at $23.23, reflecting a modest increase of 0.39%. The stock experienced a rise of 0.61% over the last month, and a significant jump of 25.41% over the past year. These figures have encouraged optimism among long-term shareholders, though potential investors may scrutinize...

Continue Reading